Saconi Eduardo Schincariol, de Carvalho Vladimir Cordeiro, de Oliveira Priscila Rosalba Domingos, Lima Ana Lúcia Lei Munhoz
Instituto de Ortopedia e Traumatologia, Hospital das Clíncias HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, SP, Brazil.
Medicine (Baltimore). 2020 Apr;99(15):e19735. doi: 10.1097/MD.0000000000019735.
The increase in the number of patients with prosthetic joints will entail a rise in the absolute number of infections associated with these procedures. Although less frequent, infections by Candida species are also expected to increase, and the clinical and surgical management of these cases is based on case reports and opinion of specialists. The objective of the present study was to review the available literature and describe the cases of prosthetic joint infection caused by Candida species in patients of the Institute of Orthopedics and Trauma of the University of São Paulo Faculty of Medicine Clinics Hospital (IOT-HCFMUSP) between 2007 and 2014.
Eleven patients were diagnosed with prosthetic joint infection due to Candida with mean age of 65 years. The most frequent comorbidities were heart disease and diabetes mellitus, and the main personal antecedent was previous bacterial infection in the prosthetic joint. At least one risk factor for fungal infection was present in 73% of the patients. There was no difference between the prevalence of infections caused by Candida albicans and non-albicans Candida species, and there was bacterial co-infection in 55% of the cases.
For building up the case series, patients with cultures of bone and joint specimens that were positive for Candida species and had a clinical diagnosis of prosthetic joint infection were included in the case series.
Surgical debridement with removal of the prosthesis was the most frequently used surgical approach (45%). All patients were treated with monotherapy, and the most frequently used antifungal agent was fluconazole. The total duration of antifungal therapy was 6 months in 73% of the cases.
After the initial management, 73% of the patients achieved clinical remission.
The most indicated initial management was debridement with removal of the prosthesis, and the most used treatment regimen was fluconazole monotherapy. The most prevalent treatment duration was 6 months. The initial management led to a favorable outcome in 73% of the cases.
Prosthetic joint infection, Candida, treatment, and diagnosis.
人工关节置换患者数量的增加将导致与这些手术相关的感染绝对数量上升。尽管念珠菌属感染相对少见,但预计其感染数量也会增加,目前这些病例的临床和外科治疗主要基于病例报告和专家意见。本研究的目的是回顾现有文献,并描述2007年至2014年期间圣保罗大学医学院临床医院骨科与创伤研究所(IOT - HCFMUSP)患者中由念珠菌属引起的人工关节感染病例。
11例患者被诊断为念珠菌所致的人工关节感染,平均年龄65岁。最常见的合并症是心脏病和糖尿病,主要个人病史是人工关节既往细菌感染。73%的患者至少存在一种真菌感染危险因素。白色念珠菌和非白色念珠菌所致感染的患病率无差异,55%的病例存在细菌合并感染。
为建立病例系列,纳入骨与关节标本培养念珠菌属阳性且临床诊断为人工关节感染的患者。
手术清创并取出假体是最常用的手术方法(45%)。所有患者均接受单一疗法治疗,最常用的抗真菌药物是氟康唑。73%的病例抗真菌治疗总疗程为6个月。
初始治疗后,73%的患者实现临床缓解。
最推荐的初始治疗是清创并取出假体,最常用的治疗方案是氟康唑单一疗法。最普遍的治疗疗程是6个月。初始治疗在73%的病例中取得了良好效果。
人工关节感染、念珠菌、治疗、诊断